SCHEMBL6309555

SCHEMBL6309555

CCOC(=O)c1ccc2nc(C)n(Cc3ccc([N+](=O)[O-])cc3Cl)c2c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.49
▸ MAPT P10636 8/20 0.44
▸ ALDH1A1 P00352 7/20 0.44
▸ LMNA P02545 4/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ GAA P10253 1/20 0.43
▸ DCTPP1 Q9H773 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ PDE2A O00408 1/20 0.43
▸ PDE10A Q9Y233 1/20 0.43
▸ ELANE P08246 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7653998 0.88 DCTPP1 (0.50) PPARGMEN1KMT2AGAADCTPP1
SCHEMBL6168664 0.87 LMNA (0.55) LMNAMEN1KMT2ADCTPP1KDM4E
SCHEMBL6173254 0.86 PPARG (0.62) PPARGMAPTALDH1A1LMNAKDM4E
SCHEMBL6301170 0.85 PPARG (0.52) PPARGMAPTALDH1A1LMNAMEN1
SCHEMBL7652168 0.85 PPARG (0.54) PPARGMAPTALDH1A1MEN1KMT2A
SCHEMBL6308856 0.85 PPARG (0.52) PPARGALDH1A1MEN1KMT2ADCTPP1
SCHEMBL7654594 0.85 PPARG (0.52) PPARGMAPTALDH1A1LMNAMEN1
SCHEMBL6304484 0.84 PPARG (0.51) PPARGMAPTALDH1A1LMNAMEN1
SCHEMBL6303281 0.84 PPARG (0.51) PPARGMAPTALDH1A1LMNAMEN1
SCHEMBL6307898 0.84 PPARG (0.51) PPARGALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6869950-B1 Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-03-22 — — US disclosed
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 — — US disclosed
EP-1142880-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-10 — — EP disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 — — EP disclosed
Send feedback